Your browser doesn't support javascript.
loading
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Titov, Ivan; Wunderink, Richard G; Roquilly, Antoine; Rodríguez Gonzalez, Daniel; David-Wang, Aileen; Boucher, Helen W; Kaye, Keith S; Losada, Maria C; Du, Jiejun; Tipping, Robert; Rizk, Matthew L; Patel, Munjal; Brown, Michelle L; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; Paschke, Amanda; Chen, Luke F.
Afiliación
  • Titov I; Department of Anesthesiology and Intensive Care, Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine.
  • Wunderink RG; Department of Medicine, Division of Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Roquilly A; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université, de Nantes, Nantes, France.
  • Rodríguez Gonzalez D; Department of Intensive Care, Hospital Civil de Guadalajara, Guadalajara, Mexico.
  • David-Wang A; Department of Medicine & Philippine General Hospital, Division of Pulmonary Medicine, University of the Philippines, Manila, Philippines.
  • Boucher HW; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
  • Kaye KS; Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Losada MC; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Du J; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Tipping R; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Rizk ML; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Patel M; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Brown ML; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Young K; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Kartsonis NA; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Butterton JR; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Paschke A; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
  • Chen LF; Merck Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
Clin Infect Dis ; 73(11): e4539-e4548, 2021 12 06.
Article en En | MEDLINE | ID: mdl-32785589
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cilastatina / Imipenem Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Ucrania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cilastatina / Imipenem Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Ucrania